Francesco Scolari Selected Research

NPHS2 protein

6/2009	Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations.
1/2006	Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome.
7/2003	Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood.
6/2003	Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
5/2003	Broadening the spectrum of diseases related to podocin mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Scolari Research Topics

Disease

18	Proteinuria 08/2022 - 12/2002
15	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2023 - 12/2002
12	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2023 - 12/2002
9	IGA Glomerulonephritis (IGA Nephropathy) 01/2023 - 04/2006
8	Lupus Nephritis 03/2024 - 03/2010
8	Kidney Diseases (Kidney Disease) 01/2023 - 12/2004
8	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2009 - 02/2003
7	Amyloidosis 09/2023 - 05/2004
6	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2024 - 09/2010
6	Chronic Kidney Failure (Chronic Renal Failure) 09/2023 - 06/2003
6	COVID-19 02/2022 - 01/2020
6	Glomerulonephritis 01/2020 - 05/2006
6	Renal Insufficiency (Renal Failure) 08/2015 - 06/2003
5	Infections 09/2023 - 01/2006
4	Inflammation (Inflammations) 03/2024 - 01/2009
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022 - 01/2021
4	Hypertension (High Blood Pressure) 08/2015 - 06/2003
3	Chronic Renal Insufficiency 01/2023 - 08/2011
3	Amyloid Plaque 12/2020 - 12/2005
3	Gout 01/2016 - 04/2012
3	Fibrosis (Cirrhosis) 08/2015 - 12/2004
3	Hypogonadism (Hypergonadotropic Hypogonadism) 06/2015 - 07/2007
3	Juvenile gout 09/2010 - 07/2003
3	Atherosclerotic Plaque (Atheroma) 05/2010 - 01/2006
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 09/2023 - 01/2023
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 01/2023
2	Late Onset Disorders 01/2023 - 05/2004
2	Sclerosis 08/2022 - 12/2002
2	Dyspnea (Shortness of Breath) 11/2020 - 01/2020
2	Lymphopenia (Lymphocytopenia) 11/2020 - 07/2020
2	Pneumonia (Pneumonitis) 07/2020 - 01/2020
2	Arthritis (Polyarthritis) 01/2016 - 09/2015
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 06/2015 - 12/2005
2	Hyperuricemia 04/2012 - 12/2004
2	Embolism (Embolus) 07/2008 - 01/2006
2	Body Weight (Weight, Body) 01/2006 - 04/2002
2	Hypercholesterolemia 02/2003 - 12/2002
1	Microscopic Polyangiitis 03/2024
1	Hereditary Nephritis (Alport Syndrome) 03/2024
1	Neoplasms (Cancer) 01/2023
1	Calcium Oxalate Nephrolithiasis 01/2023
1	Nephrocalcinosis 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Primary Hyperoxaluria (Oxaluria, Primary) 01/2023
1	Hyperoxaluria (Oxaluria) 01/2023
1	Fabry Disease (Fabry's Disease) 12/2022

Drug/Important Bio-Agent (IBA)

11	AntibodiesIBA 03/2024 - 03/2010
10	Rituximab (Mabthera)FDA Link 09/2023 - 06/2011
10	SteroidsIBA 04/2021 - 12/2002
10	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2005
7	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2023 - 05/2004
7	Immunoglobulin G (IgG)IBA 01/2023 - 03/2010
6	AutoantibodiesIBA 03/2024 - 09/2012
6	Immunoglobulin A (IgA)IBA 01/2023 - 05/2006
6	UromodulinIBA 08/2015 - 07/2003
5	CholesterolIBA 05/2010 - 01/2003
5	NPHS2 proteinIBA 06/2009 - 05/2003
4	Prednisone (Sone)FDA LinkGeneric 01/2023 - 06/2011
4	Serum AlbuminIBA 08/2022 - 01/2005
4	AntigensIBA 12/2020 - 09/2011
4	Phosphopyruvate Hydratase (Enolase)IBA 12/2020 - 09/2011
4	C-Reactive ProteinIBA 11/2020 - 01/2006
4	Blood Proteins (Serum Proteins)IBA 01/2009 - 05/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023 - 12/2019
3	ReninIBA 01/2023 - 12/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2018
3	CreatinineIBA 08/2022 - 09/2009
3	Aldehyde Reductase (Aldose Reductase)IBA 12/2020 - 03/2010
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2008
3	Calcineurin InhibitorsIBA 11/2013 - 06/2011
2	Collagen Type IV (Type IV Collagen)IBA 03/2024 - 07/2020
2	Phospholipase A2 ReceptorsIBA 09/2023 - 12/2020
2	GlucocorticoidsIBA 09/2023 - 01/2023
2	Mutant Proteins (Protein, Mutant)IBA 01/2023 - 12/2022
2	Deoxyribonucleases (DNase)FDA Link 01/2021 - 01/2020
2	Ferritins (Ferritin)IBA 07/2020 - 01/2006
2	Monoclonal AntibodiesIBA 07/2020 - 06/2012
2	Oxygen (Dioxygen)IBA 05/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 07/2007
2	Alkaline PhosphataseIBA 06/2015 - 05/2004
2	Complement System Proteins (Complement)IBA 07/2014 - 12/2002
2	Galactose (Galactopyranose)FDA LinkGeneric 10/2011 - 08/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2010 - 06/2003
2	GonadotropinsIBA 05/2008 - 07/2007
2	AlbuminsIBA 01/2008 - 11/2006
2	Hemoglobins (Hemoglobin)IBA 01/2005 - 04/2002
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2024
1	Peroxidase (Myeloperoxidase)IBA 03/2024
1	GurIBA 02/2024
1	glyoxylic acid (glyoxylate)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	OxalatesIBA 01/2023
1	Protein Sorting Signals (Signal Peptide)IBA 01/2023
1	HydrolasesIBA 12/2022
1	GlycosphingolipidsIBA 12/2022

Therapy/Procedure

14	Therapeutics 09/2023 - 01/2006
5	Renal Dialysis (Hemodialysis) 01/2022 - 04/2002
2	Transplantation 01/2023 - 03/2007
2	Kidney Transplantation 05/2020 - 06/2003
1	Drug Therapy (Chemotherapy) 01/2023